Results 171 to 180 of about 9,058 (209)
Some of the next articles are maybe not open access.
Practice Nursing, 1998
The nose is the first part of the natural airway, a fact often forgotten by doctors and nurses alike. Airflow in the nose is rapid, and during a sniff it ean easily reach the speed of a hurricane! It draws in all the airborne pollutants and particles and filters most of them out of the inhaled air before they reach the sensitive lining of the lungs ...
Sue Cross Rn, NP Dip, PGCEs
openaire +2 more sources
The nose is the first part of the natural airway, a fact often forgotten by doctors and nurses alike. Airflow in the nose is rapid, and during a sniff it ean easily reach the speed of a hurricane! It draws in all the airborne pollutants and particles and filters most of them out of the inhaled air before they reach the sensitive lining of the lungs ...
Sue Cross Rn, NP Dip, PGCEs
openaire +2 more sources
Emerging drugs for perennial allergic rhinitis
Expert Opinion on Emerging Drugs, 2012Allergic rhinitis (AR) is a high-prevalence disease, sustained by an IgE-triggered reaction with histamine release, followed by an inflammatory response which involves cells, mediators, cytokines and adhesion molecules. According to its duration, AR can be either intermittent or persistent.
Passalacqua,G, Ciprandi,G
openaire +3 more sources
Topical levocabastine for the treatment of perennial allergic rhinitis
The Journal of Laryngology & Otology, 1997AbstractThe ultrastructure of the nasal mucosa following theuse of intranasal levocabastine was studied in 20 patients suffering from perennial allergic rhinitis. The patients received twice daily 0.05 per cent levocabastine spray with a treatment duration of four weeks.
Samy Elwany, Mohamed Bassiouny
openaire +3 more sources
2018
Compared with seasonal allergic rhinitis (SAR), exposure to allergens on a year-around basis leads to persistent symptoms that can be associated with significant impairment of quality of life. As is the case with SAR, management of perennial allergic rhinitis (PAR) entails aeroallergen avoidance, pharmacotherapy, and in properly select cases allergen ...
Martin A. Smith, David M. Lang
openaire +2 more sources
Compared with seasonal allergic rhinitis (SAR), exposure to allergens on a year-around basis leads to persistent symptoms that can be associated with significant impairment of quality of life. As is the case with SAR, management of perennial allergic rhinitis (PAR) entails aeroallergen avoidance, pharmacotherapy, and in properly select cases allergen ...
Martin A. Smith, David M. Lang
openaire +2 more sources
Efficacy of montelukast for treating perennial allergic rhinitis
Allergy and Asthma Proceedings, 2007Perennial allergic rhinitis (PAR) is a chronic inflammatory nasal condition in individuals exposed year-round to allergens. This was a double-blind study of 15- to 85-year-old patients randomly allocated to montelukast, 10 mg (n=630), placebo (n=613), or the positive control cetirizine, 10 mg (n=122) for 6 weeks.
S. Balachandra Dass +8 more
openaire +2 more sources
Control of nasal obstruction in perennial allergic rhinitis
Current Opinion in Allergy and Clinical Immunology, 2004Nasal obstruction, the cardinal symptom of persistent (perennial) allergic rhinitis, is one of the most common symptoms encountered in primary care and in specialist clinics. It is difficult to quantify by clinical examination, and, hence, objective assessment of the nasal airway is critical to rhinologic research.
De Yun Wang +2 more
openaire +3 more sources
Neuronal Plasticity in Persistent Perennial Allergic Rhinitis
Journal of Occupational and Environmental Medicine, 2005Persistent perennial allergic rhinitis belongs to the most frequent diseases in occupational and environmental medicine. Because the innervation may play a role in the pathogenesis of the disease, the present study analyzed nasal mucosal nerve profiles.Neuropeptide-containing nerve fibers were examined using immunohistochemistry and related to ...
Oliver Noga +9 more
openaire +3 more sources
Pathophysiology of perennial allergic rhinitis
Allergy, 1997Allergic rhinitis involves an early phase, largely mediated through mast cells, and a late phase which involves cellular infiltration and mediator release. In the early phase, mast cells release mediators as a result of antigen crossâlinking adjacent immunoglobulin E molecules bound to mast cell surfaces.
openaire +3 more sources
Bepotastine besilate for the treatment of perennial allergic rhinitis
Expert Opinion on Pharmacotherapy, 2018Bepotastine besilate (BB) is a second-generation H1-antihistamine that, as an ophthalmic solution, is approved in the United States by the Food and Drug Administration (FDA) for the treatment of allergic conjunctivitis. In other countries, the oral presentation of BB is widely used for the improvement of symptoms of allergic rhinitis (AR) as well as ...
Ismael Carrillo-Martin +2 more
openaire +2 more sources